Journal of Antimicrobial Chemotherapy (2002) 49, 785-792
© 2002 The British Society for Antimicrobial Chemotherapy
Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996–2000
1Antimicrobial Research Laboratory, National Public Health Institute, Kiinamyllynkatu 13, 20520 Turku; 2National Reference Laboratory for Pneumococcus, National Public Health Institute, Oulu, Finland
Received 24 September 2001; returned 2 January 2002; revised 8 February 2002; accepted 15 February 2002.
The aims of this study were to evaluate the resistance patterns and serotypes/groups of penicillin non-susceptible pneumococci (PNSP) in Finland, and to determine phenotypes and resistance mechanisms of the erythromycin-resistant isolates. A total of 1190 PNSP were collected during 1996–2000 in Finland. The MICs of 18 antimicrobials were determined by the agar plate dilution method, and PCR was used to study the resistance mechanisms of the macrolide-resistant isolates. For serotyping, counterimmunoelectrophoresis and latex agglutination were used. Erythromycin resistance increased from 32% in 1996 to 62% in 2000 among PNSP in Finland. Multiresistance (co-resistance to erythromycin, tetracycline and co-trimoxazole) was present in 22% of the isolates in 1996 and in 40% in 2000. The most common macrolide resistance phenotype was the MLSB phenotype (72%), 25% had the M phenotype and 3% the MS phenotype. The MLSB and M phenotypes increased in the same proportion during the study period. All the MLSB isolates had the erm(B) gene, the M isolates the mef(A) gene, and in 11 MS isolates, ribosomal mutations were the cause of resistance. The most common serotypes/groups were 14, 19 and 6. We found a significant increase in multiresistance among PNSP within a short period of time in Finland. Although pneumococcal resistance to erythromycin was 11% in 2000, the same figure was 50% among the PNSP. The rise in erythromycin resistance is worrying, as macrolides are commonly used as first- and second-line drugs in pneumococcal infections.
* Corresponding author. Tel: +358-2-2519255; Fax: +358-2-2519254; E-mail: mapihla{at}utu.fi
Members of the Finnish Study Group for Antimicrobial Resistance are listed after the Acknowledgements.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Siira, M. Rantala, J. Jalava, A. J. Hakanen, P. Huovinen, T. Kaijalainen, O. Lyytikainen, and A. Virolainen Temporal Trends of Antimicrobial Resistance and Clonality of Invasive Streptococcus pneumoniae Isolates in Finland, 2002 to 2006 Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2066 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rantala, S. Nyberg, M. Lindgren, P. Huovinen, J. Jalava, R. Skytta, L. Teirila, A. Vainio, A. Virolainen-Julkunen, and T. Kaijalainen Molecular Epidemiology of Telithromycin-Resistant Pneumococci in Finland Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1885 - 1887. [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Phaff, H. A. W. M. Tiddens, H. A. Verbrugh, and A. Ott Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis J. Antimicrob. Chemother., April 1, 2006; 57(4): 741 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rantala, S. Huikko, P. Huovinen, J. Jalava, and the Finnish Study Group for Antimicrobial Resistan Prevalence and Molecular Genetics of Macrolide Resistance among Streptococcus pneumoniae Isolates Collected in Finland in 2002 Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4180 - 4184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. W. Klaassen and J. W. Mouton Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E) Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278. [Full Text] [PDF]
|
|
|
|
|
|
N. Bruinsma, K. G. Kristinsson, S. Bronzwaer, P. Schrijnemakers, J. Degener, E. Tiemersma, W. Hryniewicz, J. Monen, H. Grundmann, and on behalf of EARSS participants Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe J. Antimicrob. Chemother., December 1, 2004; 54(6): 1045 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Song, H.-H. Chang, J. Y. Suh, K. S. Ko, S.-I. Jung, W. S. Oh, K. R. Peck, N. Y. Lee, Y. Yang, A. Chongthaleong, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP) J. Antimicrob. Chemother., March 1, 2004; 53(3): 457 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Seppala, M. Haanpera, M. Al-Juhaish, H. Jarvinen, J. Jalava, and P. Huovinen Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora J. Antimicrob. Chemother., October 1, 2003; 52(4): 636 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pihlajamaki, J. Jalava, P. Huovinen, and P. Kotilainen Antimicrobial Resistance of Invasive Pneumococci in Finland in 1999-2000 Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1832 - 1835. [Abstract] [Full Text] [PDF]
|
|